Fedenia Advisers’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-548
Closed -$138K – 122
2026
Q2
$138K Buy
+548
New +$118K 0.03% 152
2025
Q1
– Sell
-50
Closed -$8.88K – 116
2024
Q4
$8.88K Buy
+50
New +$9.19K 0.01% 347

Other funds holding ABBV

Fedenia Advisers's ABBV Position: Q3 2026 in Review

Fedenia Advisers sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 548 shares — an estimated $138K sold.

Fedenia Advisers first reported a position in ABBV in Q4 2024 and held it in 2 quarters. The position peaked at $138K in Q2 2026. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Fedenia Advisers reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
  • Fedenia Advisers sold 548 AbbVie shares in Q3 2026, an estimated $138K.
  • Fedenia Advisers first reported a position in AbbVie in Q4 2024 and held it in 2 quarters.
  • Fedenia Advisers's AbbVie position peaked at $138K in Q2 2026.
  • 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Fedenia Advisers's 13F filing for Q3 2026, filed 22 Oct 2026.